Wolfram Tetzlaff Selected Research

GAP-43 Protein (GAP 43 Protein)

5/2007	Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury.
9/2005	Both positive and negative factors regulate gene expression following chronic facial nerve resection.
9/2004	Rubrospinal neurons fail to respond to brain-derived neurotrophic factor applied to the spinal cord injury site 2 months after cervical axotomy.
4/2002	Promoting axonal regeneration in the central nervous system by enhancing the cell body response to axotomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfram Tetzlaff Research Topics

Disease

37	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 04/2002
14	Contusions 01/2021 - 09/2007
8	Wounds and Injuries (Trauma) 01/2021 - 08/2004
8	Atrophy 04/2015 - 03/2002
5	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 06/2014
5	Stroke (Strokes) 11/2010 - 05/2008
4	Multiple Sclerosis 01/2020 - 03/2006
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 11/2010
3	Neuralgia (Stump Neuralgia) 11/2019 - 12/2012
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 09/2010
2	Gliosis 01/2020 - 03/2007
2	Autonomic Dysreflexia 12/2018 - 01/2017
2	Neoplasms (Cancer) 01/2018 - 12/2012
2	Hemorrhage 10/2008 - 04/2008
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2008 - 03/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2007 - 08/2005
2	Inflammation (Inflammations) 08/2005 - 07/2004
1	Ketosis 10/2020
1	Pain (Aches) 11/2019
1	Closed Head Injuries 01/2016
1	Crush Injuries 04/2015
1	Drug Resistant Epilepsy 01/2013
1	Infections 12/2012
1	Hypothermia 01/2012
1	Multiple Trauma (Multiple Injuries) 11/2010
1	Hypertrophy 10/2010
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2010
1	Huntington Disease (Huntington's Disease) 09/2010
1	Parkinson Disease (Parkinson's Disease) 09/2010
1	Myocardial Infarction 09/2008
1	Autoimmune Diseases (Autoimmune Disease) 08/2008
1	Fracture Dislocation 08/2008
1	Immune System Diseases (Immune Disorders) 08/2008

Drug/Important Bio-Agent (IBA)

5	Minocycline (Cyclops)FDA LinkGeneric 12/2018 - 03/2004
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2008
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2008 - 03/2002
4	Neuroprotective AgentsIBA 10/2020 - 07/2004
4	TubulinIBA 05/2007 - 04/2002
4	GAP-43 Protein (GAP 43 Protein)IBA 05/2007 - 04/2002
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 03/2007
3	Erythropoietin FDA Link 01/2012 - 09/2005
3	Messenger RNA (mRNA)IBA 09/2005 - 04/2002
2	LipidsIBA 01/2013 - 01/2012
2	Simvastatin (Zocor)FDA LinkGeneric 09/2010 - 02/2010
2	Tetracycline (Achromycin)FDA LinkGeneric 09/2010 - 08/2005
2	Hematoxylin (Haematoxylon)IBA 10/2008 - 04/2008
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2008 - 04/2008
2	BilirubinIBA 08/2008 - 03/2006
2	Amyloid beta-PeptidesIBA 08/2008 - 04/2008
2	Y 27632IBA 03/2007 - 12/2005
1	Pharmaceutical PreparationsIBA 01/2021
1	KetonesIBA 10/2020
1	SodiumIBA 10/2020
1	SaltsIBA 10/2020
1	CytokinesIBA 01/2020
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2020
1	Prostaglandins BIBA 05/2019
1	Ciliary Neurotrophic Factor (CNTF)IBA 01/2018
1	Glutathione Transferase (Glutathione S-Transferase)IBA 09/2017
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 09/2017
1	Myelin ProteinsIBA 09/2017
1	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Carisoprodol (Soma)FDA LinkGeneric 04/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	ADAM17 ProteinIBA 01/2016
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 12/2014
1	CarbohydratesIBA 01/2013
1	ElementsIBA 05/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	Riluzole FDA LinkGeneric 01/2012
1	Hormones (Hormone)IBA 01/2012
1	AntioxidantsIBA 01/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2012
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2012
1	calpain inhibitorsIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	MagnesiumIBA 11/2010
1	RolipramIBA 10/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2010
1	Atorvastatin (Lipitor)FDA Link 02/2010
1	Complement System Proteins (Complement)IBA 06/2009
1	Cytochromes c (Cytochrome c)IBA 08/2008
1	Immunologic Factors (Immunomodulators)IBA 08/2008
1	Dextrans (Dextran)FDA Link 08/2008

Therapy/Procedure

17	Therapeutics 01/2020 - 07/2002
8	Transplantation 01/2020 - 09/2002
7	Axotomy 04/2016 - 03/2002
4	Cell Transplantation 01/2020 - 08/2011
3	Diet Therapy (Therapy, Diet) 01/2021 - 09/2008
3	Ketogenic Diet 01/2021 - 01/2013
2	Decompression 01/2020 - 01/2019
2	Investigational Therapies (Experimental Therapy) 09/2004 - 07/2002
1	Surgical Decompression 01/2020
1	Transjugular Intrahepatic Portasystemic Shunt 11/2019
1	Drug Therapy (Chemotherapy) 12/2012
1	Biological Therapy 08/2011
1	Intravenous Injections 05/2008
1	Treatment Delay 05/2008